REFERENCES
- Ueda J, Yue B YJT. Distribution of myocilin and extracellular matrix components in the corneoscleral meshwork of human eyes. Invest Ophthalmol Vis Sci. 2003; 44: 4772–4779, [PUBMED], [INFOTRIEVE], [CSA]
- Fini M E, Parks W C, Rinehart W B, et al. Role of matrix metalloproteinases in failure to re-epithelialize after corneal injury. Am J Pathol. 1996; 149: 1287–1302, [PUBMED], [INFOTRIEVE], [CSA]
- Sivak J M, Fini M E. MMPs in the eye: Emerging roles for matrix metalloproteinases in ocular physiology. Prog Retin Eye Res. 2002; 21: 1–14, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Cameron J A. Shield ulcers and plaques of the cornea in vernal keratoconjunctivitis. Ophthalmology. 1995; 102: 985–993, [PUBMED], [INFOTRIEVE], [CSA]
- Bonini S, Coassin M, Aronni S, Lambiase A. Vernal keratoconjunctivitis. Eye 2004; 18: 345–351, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Okada Y, Morodomi T, Enghild J J, et al. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. Eur J Biochem. 1990; 194: 721–730, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Okada Y, Gonoji Y, Naka K, et al. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J Biol Chem. 1992; 267: 21712–21719, [PUBMED], [INFOTRIEVE], [CSA]
- Kumagai N, Yamamoto K, Fukuda K, et al. Active matrix metalloproteinases in the tear fluid of individuals with vernal keratoconjunctivitis. J Allergy Clin Immunol. 2002; 110: 489–491, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ohbayashi H, Shimokata K. Matrix metalloproteinase-9 and airway remodeling in asthma. Curr Drug Targets Inflamm Allergy 2005; 4: 177–181, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Schwartz L B, Bradford T R, Irani A M, et al. The major enzymes of human mast cell secretory granules. Am Rev Respir Dis. 1987; 135: 1186–1189, [PUBMED], [INFOTRIEVE], [CSA]
- Payne V, Kam P CA. Mast cell tryptase: A review of its physiology and clinical significance. Anaesthesia 2004; 59: 695–703, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Tabbara K F. Tear tryptase in vernal keratoconjunctivitis. Arch Ophthalmol. 2001; 119: 338–342, [PUBMED], [INFOTRIEVE], [CSA]
- Dery O, Corvera C U, Steinhoff M, Bunnett N W. Proteinase-activated receptors: Novel mechanisms of signaling by serine proteases. Am J Physiol. 1998; 274: C1429–C1452, [PUBMED], [INFOTRIEVE], [CSA]
- Vliagoftis H, Schwingshackl A, Milne C D, et al. Proteinase-activated receptor-2-mediated matrix metalloproteinase-9 release from airway epithelial cells. J Allergy Clin Immunol. 2000; 106: 537–545, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lees M, Taylor D J, Woolley D E. Mast cell proteinases activate precursor forms of collagenase and stromelysin, but not of gelatinases A and B. Eur J Biochem. 1994; 223: 171–177, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Solomon A, Puxeddu I, Levi-Schaffer F. Fibrosis in ocular allergic inflammation: Recent concepts in the pathogenesis of ocular allergy. Curr Opin Allergy Clin Immunol. 2003; 3: 389–393, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Matsubara M, Girard M T, Kublin C L, et al. Differential roles for two gelatinolytic enzymes of the matrix metalloproteinase family in the remodeling cornea. Dev Biol. 1991; 147: 425–439, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Fini M E, Cook J R, Mohan R. Proteolytic mechanisms in corneal ulceration and repair. Arch Dermatol Res. 1998; 290: S12–S23, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kumagai N, Fukuda K, Ishimura Y, Nishida T. Synergistic induction of eotaxin expression in human keratocytes by TNF-α and IL-4 or IL-13. Invest Ophthalmol Vis Sci. 2000; 41: 1448–1453, [PUBMED], [INFOTRIEVE], [CSA]
- Kumagai N, Fukuda K, Nishida T. Synergistic effect of TNF-α and IL-4 on the expression of thymus- and activation-regulated chemokine in human corneal fibroblasts. Biochem Biophys Res Commun. 2000; 279: 1–5, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Nagano T, Hao J L, Nakamura M, et al. Stimulatory effect of pseudomonal elastase on collagen degradation by cultured keratocytes. Invest Ophthalmol Vis Sci. 2001; 42: 1247–1253, [PUBMED], [INFOTRIEVE], [CSA]
- Cakarovski K, Leung J Y, Restall C, et al. Novel inhibitors of urokinase-type plasminogen activator and matrix metalloproteinase expression in metastatic cancer cell lines. Int J Cancer 2004; 110: 610–616, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Vergnolle N. Proteinase-activated receptor-2-activating peptides induce leukocyte rolling, adhesion, and extravasation in vivo. J Immunol. 1999; 163: 5064–5069, [PUBMED], [INFOTRIEVE], [CSA]
- Sato H, Takino T, Okada Y, et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994; 370: 61–65, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Atkinson S J, Crabbe T, Cowell S, et al. Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes. J Biol Chem. 1995; 270: 30479–30485, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Butler G S, Butler M J, Atkinson S J, et al. The TIMP2 membrane type 1 metalloproteinase “receptor” regulates the concentration and efficient activation of progelatinase A. A kinetic study. J Biol Chem. 1998; 273: 871–880, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hernandez-Barrantes S, Toth M, Bernardo M M, et al. Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation. J Biol Chem. 2000; 275: 12080–12089, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Will H, Atkinson S J, Butler G S, et al. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. J Biol Chem. 1996; 271: 17119–17123, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ottino P, He J, Axelrad T W, Bazan H EP. PAF-induced furin and MT1-MMP expression is independent of MMP-2 activation in corneal myofibroblasts. Invest Ophthalmol Vis Sci. 2005; 46: 487–496, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Dushku N, John M K, Schultz G S, Reid T W. Pterygia pathogenesis: Corneal invasion by matrix metalloproteinase expressing altered limbal epithelial basal cells. Arch Ophthalmol. 2001; 119: 695–706, [PUBMED], [INFOTRIEVE], [CSA]
- Kumagai N, Fukuda K, Fujitsu Y, Nishida T. Synergistic effect of TNF-α and either IL-4 or IL-13 on VCAM-1 expression by cultured human corneal fibroblasts. Cornea 2003; 22: 557–561, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kumagai N, Fukuda K, Fujitsu Y, Nishida T. Expression of functional ICAM-1 on cultured human keratocytes induced by tumor necrosis factor-α. Jpn J Ophthalmol. 2003; 47: 134–141, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Corry D B, Rishi K, Kanellis J, et al. Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency. Nat Immunol. 2002; 3: 347–353, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]